Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Tongxin Liu,Quanquan Sun,Qi Li,Hua Yang,Yuqin Zhang,Rong Wang,Xiaoshan Lin,Dong Xiao,Yawei Yuan,Longhua Chen,Wei Wang

DOI: https://doi.org/10.1158/1535-7163.22502823

2023-01-01

Abstract:Supplementary Figure legends

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma

Qingsheng Xu,Kaiyuan Huang,Xiangqi Meng,Yuxiang Weng,Luyuan Zhang,Linghao Bu,Xiujue Zheng,Jinquan Cai,Renya Zhan,Qun Chen

DOI: https://doi.org/10.1158/1078-0432.24228964

2023-01-01

Abstract:A-B. Kaplan-Meier plots of progression-free survival and overall survival (Full analysis set). The x-axes indicated times since enrollment.
Supplementary Figure S4 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma

Qingsheng Xu,Kaiyuan Huang,Xiangqi Meng,Yuxiang Weng,Luyuan Zhang,Linghao Bu,Xiujue Zheng,Jinquan Cai,Renya Zhan,Qun Chen

DOI: https://doi.org/10.1158/1078-0432.24228961

2023-01-01

Abstract:A-B. Kaplan-Meier plots of progression-free survival and overall survival (Full analysis set). The x-axes indicated times since enrollment.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong,Lu Si,Yiqian Li,Xiaowen Wu,Xiaowei Xu,Jie Dai,Huan Tang,Meng Ma,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Jun Guo

DOI: https://doi.org/10.1158/1078-0432.22461800.v1

2023-01-01

Abstract:Figure legends for Supplementary Figure S1 and Figure S2
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Dalong Cao,Zihao Qi,Yangyang Pang,Haoran Li,Huyang Xie,Junlong Wu,Yongqiang Huang,Yao Zhu,Yijun Shen,Yiping Zhu,Bo Dai,Xin Hu,Dingwei Ye,Ziliang Wang

DOI: https://doi.org/10.1158/0008-5472.22418970

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Amanda Herzog,Yansong Bian,Robert Vander Broek,Bradford Hall,Jamie Coupar,Hui Cheng,Anastasia L. Sowers,John D. Cook,James B. Mitchell,Zhong Chen,Ashok B. Kulkarni,Carter Van Waes

DOI: https://doi.org/10.1158/1078-0432.22445265

2023-01-01

Abstract:PDF file - 1957K, Treatment in UM-SCC xenograft and Tgfbr1/Pten KO mice.
Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Jeff Hsu,Colin Chong,Jeffrey Serrill,Levina Goon,Joan Balayan,Eric N. Johnson,Grachelle Lorenzana,Sharon Wu,Kevin G. Leong,Theodore J. Yun,Yong Wang,Faming Jiang,Lynne Bannen,Peter Lamb,Wei Xu,Peiwen Yu

DOI: https://doi.org/10.1158/1535-7163.22523460

2023-01-01

Abstract:Supplementary Figures and Tables with adjoining Legends
Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387137.v1

2023-01-01

Abstract:Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu,Monika L. Burness,Rachel Martin-Trevino,Joey Guy,Shoumei Bai,Ramdane Harouaka,Michael Brooks,Shang Li,Alex Fox,Tahra Luther,April Davis,Trenton L. Baker,Justin A. Colacino,Shawn G. Clouthier,Zhi‐Ming Shao,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/1078-0432.22460774.v1

2023-01-01

Abstract:Supplementary figures 1-8 legends
Supplementary Figures and Figure Legends from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Tao Yu,Yingjun Zhao,Zhixiang Hu,Jing Li,Dandan Chu,Jiwei Zhang,Zhe Li,Bing Chen,Xiao Zhang,Hongyu Pan,Shengli Li,Hechun Lin,Lei Liu,Mingxia Yan,Xianghuo He,Ming Yao

DOI: https://doi.org/10.1158/0008-5472.22418432.v1

2023-01-01

Abstract:<p>Supplementary Figures and Figure legends that contain the information of the characteristics of MetaLnc9 in NSCLC, Non-coding RNA analysis, the efficiency for MetaLnc9 overexpression and Knockdown, the molecular mechanism of PGK1 and NONO.</p>
Supplementary Figure from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Jiayong Liu,Tian Gao,Zhichao Tan,Shu Li,Jie Xu,Chujie Bai,Ruifeng Xue,Lu Xie,Lu Zhang,Zhengfu Fan,Wei Guo

DOI: https://doi.org/10.1158/1078-0432.ccr-22-0871

IF: 13.801

2022-01-01

Clinical Cancer Research

Abstract:Supplementary Figure from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Xin Zheng,Xiaolei Fan,Binqing Fu,Ming–Hua Zheng,Aimei Zhang,Kai Zhong,Jun Yan,Rui Sun,Zhigang Tian,Wei H

DOI: https://doi.org/10.1158/0008-5472.22414839.v1

2023-01-01

Abstract:Supplementary Figure 1-6 legends
Supplementary Figure Legends from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Xiaohong Wang,Qiaoyi Liang,Lianhai Zhang,Hongyan Gou,Ziyu Li,Huarong Chen,Dong Yang,Jiafu Ji,Yuanyuan Wang

DOI: https://doi.org/10.1158/1078-0432.22468316.v1

2023-01-01

Abstract:Supplementary Figure legends
Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Hong Zhu,Dan-Dan Wang,Tao Yuan,Fang-Jie Yan,Chen-Ming Zeng,Xiao-Yang Dai,Zi-bo Chen,Ying Chen,Tianyi Zhou,Guang-Han Fan,Meidan Ying,Ji Cao,Peihua Luo,Xi-Jie Liu,Yuandong Hu,Yong Peng,Qiaojun He,Bo Yang

DOI: https://doi.org/10.1158/0008-5472.22417226.v1

2023-01-01

Abstract:Materials and Methods for Supplemental Figures
Supplementary Data from Fimepinostat Impairs NFκB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma

Dan Wang,Kun Yan,Hongxing Yu,Haocheng Li,Wei Zhou,Yaqiang Hong,Shuning Guo,Yi Wang,Cheng Xu,Changcun Pan,Yujie Tang,Nian Liu,Wei Wu,Liwei Zhang,Qiaoran Xi

DOI: https://doi.org/10.1158/0008-5472.25224448

2024-01-01

Abstract:Supplementary Figures 1-7; Supplementary Tables 1-8
Supplementary Methods, Figure Legends 1-3 from Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134

Sheng‐Ben Liang,Yang Xia,Young Trieu,Zhihua Li,Jessica Zive,Chungyee Leung-Hagesteijn,Ellen Wei,Sergey Zozulya,Christopher C. Coss,James T. Dalton,I. George Fantus,Suzanne Trudel

DOI: https://doi.org/10.1158/1078-0432.22442385

2023-01-01

Abstract:Supplementary Methods, Figure Legends 1-3 from Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134
Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387134.v1

2023-01-01

Abstract:Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma

Supplementary Figure S4 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure Legends from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Supplementary Figures and Figure Legends from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Figure from Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Supplementary Figure Legends from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Supplementary Data from Fimepinostat Impairs NF­κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma

Supplementary Methods, Figure Legends 1-3 from Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134

Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Data from Fimepinostat Impairs NFκB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma